Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS)
CNY 8.95
(-0.67%)
CNY 8.95
(-0.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.18 Billion CNY | -29.52% |
| 2022 | 2 Billion CNY | 1.83% |
| 2021 | 1.94 Billion CNY | -5.83% |
| 2020 | 2.19 Billion CNY | -36.77% |
| 2019 | 1.92 Billion CNY | 195.29% |
| 2018 | 1.02 Billion CNY | -17.15% |
| 2017 | 1.29 Billion CNY | 19.07% |
| 2016 | 1.07 Billion CNY | 19.19% |
| 2015 | 985.6 Million CNY | -31.86% |
| 2014 | 1.43 Billion CNY | 24.55% |
| 2013 | 1.14 Billion CNY | 52.54% |
| 2012 | 726.38 Million CNY | -22.25% |
| 2011 | 950.12 Million CNY | 25.7% |
| 2010 | 743.26 Million CNY | 19.72% |
| 2009 | 639.13 Million CNY | 26.42% |
| 2008 | 515.61 Million CNY | 17.68% |
| 2007 | 433.31 Million CNY | 48.86% |
| 2006 | 303.51 Million CNY | -7.29% |
| 2005 | 327.36 Million CNY | -22.93% |
| 2004 | 424.77 Million CNY | 21.84% |
| 2003 | 348.63 Million CNY | 138.28% |
| 2002 | 146.31 Million CNY | 30.74% |
| 2001 | 111.91 Million CNY | 10.56% |
| 2000 | 94.57 Million CNY | 14.7% |
| 1999 | 87.91 Million CNY | 55.46% |
| 1998 | 56.66 Million CNY | -11.65% |
| 1997 | 64.24 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 436.32 Million CNY | -9.45% |
| 2024 Q3 | 155.71 Million CNY | -70.19% |
| 2024 Q1 | 351.91 Million CNY | 270.57% |
| 2023 FY | - CNY | -29.52% |
| 2023 Q4 | -386.28 Million CNY | -395.22% |
| 2023 Q3 | 130.84 Million CNY | -62.1% |
| 2023 Q2 | 345.28 Million CNY | -7.38% |
| 2023 Q1 | 372.78 Million CNY | 48.19% |
| 2022 Q3 | 245.32 Million CNY | -22.02% |
| 2022 Q2 | 314.6 Million CNY | 7.64% |
| 2022 Q1 | 292.28 Million CNY | 78.92% |
| 2022 FY | - CNY | 1.83% |
| 2022 Q4 | 251.55 Million CNY | 2.54% |
| 2021 Q2 | 277.19 Million CNY | -23.61% |
| 2021 FY | - CNY | -5.83% |
| 2021 Q4 | 163.35 Million CNY | -53.32% |
| 2021 Q3 | 349.97 Million CNY | 26.26% |
| 2021 Q1 | 362.88 Million CNY | 17.13% |
| 2020 Q1 | 206.86 Million CNY | -64.61% |
| 2020 Q4 | 309.81 Million CNY | 12.16% |
| 2020 FY | - CNY | -36.77% |
| 2020 Q3 | 276.23 Million CNY | -52.24% |
| 2020 Q2 | 578.33 Million CNY | 179.57% |
| 2019 Q1 | 343.59 Million CNY | 395.28% |
| 2019 Q3 | 1.44 Billion CNY | 424.08% |
| 2019 Q4 | 584.55 Million CNY | -59.58% |
| 2019 FY | - CNY | 195.29% |
| 2019 Q2 | 275.93 Million CNY | -19.69% |
| 2018 Q2 | 249.1 Million CNY | -5.88% |
| 2018 Q3 | 59.94 Million CNY | -75.94% |
| 2018 Q4 | -116.36 Million CNY | -294.11% |
| 2018 FY | - CNY | -17.15% |
| 2018 Q1 | 264.65 Million CNY | 55.42% |
| 2017 Q2 | 198.29 Million CNY | -12.21% |
| 2017 FY | - CNY | 19.07% |
| 2017 Q3 | 130.12 Million CNY | -34.38% |
| 2017 Q4 | 170.28 Million CNY | 30.86% |
| 2017 Q1 | 225.88 Million CNY | -28.35% |
| 2016 FY | - CNY | 19.19% |
| 2016 Q4 | 315.24 Million CNY | 4083.67% |
| 2016 Q3 | 7.53 Million CNY | -95.81% |
| 2016 Q2 | 180.02 Million CNY | 1.99% |
| 2016 Q1 | 176.5 Million CNY | -40.5% |
| 2015 Q4 | 296.65 Million CNY | 768.43% |
| 2015 Q3 | -44.38 Million CNY | -130.68% |
| 2015 FY | - CNY | -31.86% |
| 2015 Q1 | 108.49 Million CNY | -72.57% |
| 2015 Q2 | 144.63 Million CNY | 33.31% |
| 2014 Q2 | 241.24 Million CNY | -7.23% |
| 2014 FY | - CNY | 24.55% |
| 2014 Q4 | 395.54 Million CNY | 112.17% |
| 2014 Q3 | 186.43 Million CNY | -22.72% |
| 2014 Q1 | 260.05 Million CNY | 15.21% |
| 2013 FY | - CNY | 52.54% |
| 2013 Q3 | 175.57 Million CNY | 10.1% |
| 2013 Q2 | 159.46 Million CNY | -37.16% |
| 2013 Q1 | 253.78 Million CNY | 131.95% |
| 2013 Q4 | 225.71 Million CNY | 28.56% |
| 2012 Q3 | 118.17 Million CNY | -27.27% |
| 2012 FY | - CNY | -22.25% |
| 2012 Q2 | 162.47 Million CNY | 45.05% |
| 2012 Q4 | 109.41 Million CNY | -7.41% |
| 2012 Q1 | 112.01 Million CNY | -51.93% |
| 2011 Q3 | 153.31 Million CNY | -14.55% |
| 2011 FY | - CNY | 25.7% |
| 2011 Q4 | 233.03 Million CNY | 52.0% |
| 2011 Q1 | 146.46 Million CNY | -27.62% |
| 2011 Q2 | 179.41 Million CNY | 22.49% |
| 2010 FY | - CNY | 19.72% |
| 2010 Q1 | 104.42 Million CNY | -17.63% |
| 2010 Q3 | 134.9 Million CNY | 30.58% |
| 2010 Q4 | 202.34 Million CNY | 49.99% |
| 2010 Q2 | 103.31 Million CNY | -1.07% |
| 2009 Q3 | 135.04 Million CNY | 25.05% |
| 2009 Q2 | 107.99 Million CNY | 18.12% |
| 2009 FY | - CNY | 26.42% |
| 2009 Q1 | 91.42 Million CNY | 2.7% |
| 2009 Q4 | 126.78 Million CNY | -6.12% |
| 2008 FY | - CNY | 17.68% |
| 2008 Q1 | 82.97 Million CNY | 20.12% |
| 2008 Q2 | 87.76 Million CNY | 5.77% |
| 2008 Q4 | 89.01 Million CNY | -6.27% |
| 2008 Q3 | 94.97 Million CNY | 8.21% |
| 2007 Q2 | 65.86 Million CNY | 8.24% |
| 2007 Q1 | 60.84 Million CNY | -33.48% |
| 2007 FY | - CNY | 48.86% |
| 2007 Q4 | 69.07 Million CNY | -23.6% |
| 2007 Q3 | 90.41 Million CNY | 37.27% |
| 2006 Q3 | 71.58 Million CNY | -5.21% |
| 2006 Q1 | 76.85 Million CNY | 3.83% |
| 2006 FY | - CNY | -7.29% |
| 2006 Q4 | 91.46 Million CNY | 27.77% |
| 2006 Q2 | 75.52 Million CNY | -1.74% |
| 2005 FY | - CNY | -22.93% |
| 2005 Q3 | 77.38 Million CNY | -13.01% |
| 2005 Q4 | 74.02 Million CNY | -4.34% |
| 2005 Q1 | 86.03 Million CNY | 19.9% |
| 2005 Q2 | 88.96 Million CNY | 3.41% |
| 2004 Q3 | 106.79 Million CNY | -13.98% |
| 2004 Q4 | 71.75 Million CNY | -32.82% |
| 2004 Q1 | 112.62 Million CNY | 38.27% |
| 2004 Q2 | 124.16 Million CNY | 10.24% |
| 2004 FY | - CNY | 21.84% |
| 2003 Q2 | 99.86 Million CNY | 76.28% |
| 2003 Q1 | 56.65 Million CNY | 47.58% |
| 2003 FY | - CNY | 138.28% |
| 2003 Q4 | 81.44 Million CNY | -22.83% |
| 2003 Q3 | 105.54 Million CNY | 5.68% |
| 2002 FY | - CNY | 30.74% |
| 2002 Q2 | 17.64 Million CNY | 20.55% |
| 2002 Q1 | 14.63 Million CNY | 0.0% |
| 2002 Q3 | 18.71 Million CNY | 6.06% |
| 2002 Q4 | 38.39 Million CNY | 105.12% |
| 2001 FY | - CNY | 10.56% |
| 2000 FY | - CNY | 14.7% |
| 1999 FY | - CNY | 55.46% |
| 1998 FY | - CNY | -11.65% |
| 1997 FY | - CNY | 0.0% |